ADMA Biologics, Inc. (ADMA) revenue

Revenue · fiscal 2025
$510.17M

ADMA Biologics, Inc. (ADMA) reported revenue of $510.17M in fiscal 2025 (the year ended December 31, 2025). That is 19.6% higher than the $426.45M of fiscal 2024. Figures as of 18 Nov 2026, 07:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$510.17M
Change on fiscal 2024
+19.6%
Growth, 5 years
+64.6% a year
Growth, 10 years
+53.2% a year
Highest on record
$510.17Mfiscal 2025
Lowest on record
$761.04Kfiscal 2011
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ADMA Biologics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 64.6% a year; over ten years the rate was 53.2% a year. Across the 15 fiscal years on record (2011–2025), the highest was $510.17M in fiscal 2025 and the lowest $761.04K in fiscal 2011.

History · 15 fiscal years

Revenue by fiscal year

ADMA Biologics, Inc. revenue, year by year

ADMA Biologics, Inc. (ADMA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$510.17M 19.6% up
2024$426.45M 65.2% up
2023$258.22M 67.6% up
2022$154.08M 90.4% up
2021$80.94M 91.7% up
2020$42.22M 43.9% up
2019$29.35M 72.8% up
2018$16.99M 25.4% down
2017$22.76M 113.5% up
2016$10.66M 48.5% up
2015$7.18M 21.3% up
2014$5.92M 92.8% up
2013$3.07M 174.4% up
2012$1.12M 46.9% up
2011$761.04K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on ADMA

ADMA Biologics, Inc., figure by figure

ADMA Biologics, Inc. (ADMA) overview: price, valuation and scorecard

ADMA Biologics, Inc. revenue: questions and answers

What is ADMA Biologics, Inc.'s revenue?

ADMA Biologics, Inc. (ADMA) reported revenue of $510.17M in fiscal 2025 (the year ended December 31, 2025). That is 19.6% higher than the $426.45M of fiscal 2024.

What is the growth rate of ADMA Biologics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 64.6% a year; over ten years the rate was 53.2% a year.

What are the highest and lowest revenue figures on record for ADMA Biologics, Inc.?

Across the 15 fiscal years on record (2011–2025), the highest was $510.17M in fiscal 2025 and the lowest $761.04K in fiscal 2011.

How is ADMA Biologics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ADMA Biologics, Inc. (ADMA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ADMA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.